Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-21

Clinical Trial Update: A Real-world Prospective Observational Study on the Efficacy and Safety of L-AmB(Liposomal Amphotericin B) for br- IFD(Breakthrough Invasive Fungal Disease) in Children and Adolescent Patients With Hematological Malignancies Receiving Triazoles or Echinocandins Prophylaxis

View source ↗

Summary

This clinical trial update describes a real-world prospective observational study evaluating the safety and efficacy of liposomal amphotericin B (L-AmB) for bre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMBISOME (AMPHOTERICIN B)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Fungal Disease | Status: RECRUITING